ilomastat has been researched along with Disease Models, Animal in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baggio, C; Fragai, M; Nordgren, TM; Pellecchia, M; Velazquez, JV | 1 |
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Levine, MA; Lukowski, ZL; Martorana, GM; Meyers, CA; Min, J; Schaefer, JL; Schultz, GS; Sherwood, MB | 1 |
| Wang, W; Wang, YD | 1 |
| Bencsik, P; Csonka, C; Csont, T; Ferdinandy, P; Giricz, Z; Görbe, A; Kocsis, GF; Kupai, K; Murlasits, Z; Pipis, J; Puskás, LG; Varga-Orvos, Z | 1 |
| Cho, YB; Choi, CH; Jang, CH; Jo, SY; Kim, MY; Park, BY | 1 |
| Antonelli, PJ; Barr, PJ; Pemberton, PA; Schultz, GS; Sundin, DJ | 1 |
| Khaw, PT; Mead, AL; Wong, TT | 1 |
| Sherwood, MB | 1 |
| Hosokawa, T; Inoue, T; Kosaku, K; Maeda, N; Sawa, M; Yokoyama, T; Yoshida, Y | 1 |
10 other study(ies) available for ilomastat and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic Targeting of MMP-12 for the Treatment of Chronic Obstructive Pulmonary Disease.
Topics: Animals; Binding Sites; Crystallography, X-Ray; Disease Models, Animal; Emphysema; Half-Life; Humans; Isoenzymes; Matrix Metalloproteinase 12; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Molecular Dynamics Simulation; Nuclear Magnetic Resonance, Biomolecular; Pancreatic Elastase; Peptides; Pulmonary Disease, Chronic Obstructive; Structure-Activity Relationship | 2020 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Sequential Therapy with Saratin, Bevacizumab and Ilomastat to Prolong Bleb Function following Glaucoma Filtration Surgery in a Rabbit Model.
Topics: Analysis of Variance; Angiogenesis Inhibitors; Animals; Antibiotics, Antineoplastic; Bevacizumab; Blister; Combined Modality Therapy; Conjunctiva; Disease Models, Animal; Drug Therapy, Combination; Filtering Surgery; Glaucoma; Hydroxamic Acids; Indoles; Injections; Mitomycin; Postoperative Period; Rabbits; Salivary Proteins and Peptides; Time Factors; Treatment Outcome; Wound Healing | 2015 |
Protective effect of ilomastat on trinitrobenzenesulfonic acid-induced ulcerative colitis in rats.
Topics: Animals; Anti-Inflammatory Agents; Colitis, Ulcerative; Colon; Disease Models, Animal; Dose-Response Relationship, Drug; Gastrointestinal Agents; Hydroxamic Acids; Immunohistochemistry; Indoles; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase Inhibitors; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-1; Trinitrobenzenesulfonic Acid | 2008 |
Role of iNOS and peroxynitrite-matrix metalloproteinase-2 signaling in myocardial late preconditioning in rats.
Topics: Animals; Disease Models, Animal; Enzyme Activation; Hydroxamic Acids; Indoles; Ischemic Preconditioning, Myocardial; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type II; Peroxynitrous Acid; Protease Inhibitors; Rats; Rats, Wistar; Signal Transduction; Superoxide Dismutase; Superoxides; Time Factors; Up-Regulation | 2010 |
Matrix metalloproteinase inhibitor attenuates cochlear lateral wall damage induced by intratympanic instillation of endotoxin.
Topics: Animals; Anti-Bacterial Agents; Cochlea; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Guinea Pigs; Hearing Loss; Hydroxamic Acids; Indoles; Instillation, Drug; Labyrinthitis; Lipopolysaccharides; Male; Matrix Metalloproteinase Inhibitors; Oxytetracycline | 2012 |
Protease inhibitors alpha1-antitrypsin and ilomastat are not ototoxic in the chinchilla.
Topics: alpha 1-Antitrypsin; Animals; Chinchilla; Disease Models, Animal; Female; Hearing; Hydroxamic Acids; Indoles; Instillation, Drug; Male; Otitis Media; Serine Proteinase Inhibitors; Temporal Bone | 2003 |
Prolonged antiscarring effects of ilomastat and MMC after experimental glaucoma filtration surgery.
Topics: Animals; Antibiotics, Antineoplastic; Cicatrix; Conjunctiva; Disease Models, Animal; Enzyme Inhibitors; Female; Filtering Surgery; Glaucoma; Hydroxamic Acids; Indoles; Injections; Intraoperative Care; Matrix Metalloproteinase Inhibitors; Mitomycin; Postoperative Care; Prospective Studies; Rabbits; Sclera; Wound Healing | 2005 |
A sequential, multiple-treatment, targeted approach to reduce wound healing and failure of glaucoma filtration surgery in a rabbit model (an American Ophthalmological Society thesis).
Topics: Alkylating Agents; Animals; Antimetabolites; Blister; Conjunctiva; Connective Tissue; Connective Tissue Growth Factor; Disease Models, Animal; Drug Delivery Systems; Filtering Surgery; Glaucoma; Hydroxamic Acids; Immediate-Early Proteins; Indoles; Intercellular Signaling Peptides and Proteins; Intraocular Pressure; Male; Mannosephosphates; Mitomycin; Oligodeoxyribonucleotides, Antisense; Rabbits; Transforming Growth Factor beta2; Treatment Failure; Wound Healing | 2006 |
[Effect of matrix metalloproteinase inhibitor on experimental pseudomonal corneal ulceration].
Topics: Animals; Cornea; Corneal Ulcer; Disease Models, Animal; Enzyme Inhibitors; Guinea Pigs; Indoles; Keratitis; Male; Metalloendopeptidases; Pseudomonas Infections | 1998 |